Purpose of review Well-functioning romantic relationships are important for long-term health and well being, but they are often difficult to sustain. This difficulty arises (in part) because of an underlying tension between our psychobiological natures, culture/environment, and modern love and relationship goals. One possible solution to this predicament is to intervene at the level of psychobiology, enhancing partners' interpersonal connection through neurochemical modulation. This article focuses on a single, promising biobehavioral sub-system for such intervention: the attachment system, based largely upon the expression of the neuropeptide oxytocin. Could the exogenous administration of oxytocin -under the right conditions -be used to facilitate relational or marital well being?
INTRODUCTION
In a recent publication, Earp et al. [1 & ] argued that the well-documented fragility of modern marriages may trace (in large part) to a set of deeply-rooted disparities: between human psychobiology, the modern environment, and widespread cultural and ethical ideals concerning love and relationships. Natural selection did not shape our basic mating strategies -nor our underlying brain chemistry -to foster life-long, monogamous matrimony in the modern world, but rather to promote the reproductive success of our progenitors in the environment of the Pleistocene [2, 3] . Just as with pair bonding in other species, it has been suggested , 9, 10] . Despite the earnest desire of a majority of individuals to enter into life-long relationships [11] , marital dissatisfaction is common, and positive, healthy relationships are often difficult to sustain.
Yet remaining in a good marriage can bring a range of important benefits. These include resilience against the negative effects of life stressors [12, 13] , higher self-ratings of health and well being [14] , lower rates of diagnosed psychological disorders [13] , greater life expectancy [14] , fewer diagnosable health problems [15] , improved coping with major illnesses [16] , greater career achievement [17] , and fewer financial problems [18] . In contrast, relationship discord has been found to be the most frequent cause of emotional distress [19] with outright relationship failure (in the form of break up or divorce) often resulting in prolonged periods of depression [20] , permanent damage to life satisfaction [21] , and long-lasting collateral harm to children when they are involved as well [22, 23] . Although achieving relationship satisfaction is a primary goal for most individuals, only 37% of couples claim to be very happy in their marriage [24] .
How might this situation be addressed? Typically, couples experiencing difficulties desire to improve their relationship and for many of them it is beneficial to do so. In addition to the general health and well being advantages of building a wellfunctioning relationship, individuals often have hedonic, economic, religious, cultural, and/or social reasons to enhance their love [2] . There are several methods that couples might employ to ameliorate their marriage or relationship. These include focusing on the positive aspects of the relationship, nurturing commitment, and prioritizing sex and intimacy [25] . When these methods fail, couples might try marital therapy or relationship counseling.
Meta-analyses and systematic reviews indicate that a range of common therapies can indeed be effective in relieving couple distress in many situations [26, 27] . However, 'research also indicates that a sizeable percentage of couples fail to achieve significant gains from couple therapy or show significant deterioration afterward' ( [28] , p. 317). As the fecund field of relationship counseling approaches its first centenary [29] , therefore, there is reason to ask whether standard therapeutic strategies might be improved and/or productively complemented going forward.
Given the hypothesized tension between our inherent psychobiology and our conscious marriage/relationship goals, it has recently been suggested that direct intervention on the biochemical side of the equation might be a promising avenue to explore [1 & ,2]. Savulescu and Sandberg [2] argued that pharmacological administrationsbased on existing and near-future developments in neuroscience and biotechnology -could be used to improve relationship health and satisfaction. Specifically, they suggested that the chemical
KEY POINTS
Intranasal oxytocin may hold promise for the therapeutic neuroenhancement of modern relationships. Oxytocin has 'good' and 'bad' effects, however, that may be different for different individuals and couples depending upon a range of personal, interpersonal, and contextual factors.
Large-scale clinical trials with adequate sample sizes, and that include both males and females, are needed to fill in a range of gaps in existing knowledge. Chronic administrations and ecologically valid study designs should be top research priorities.
The imminent prospect of neurochemical modulation of interpersonal relationships should inspire the development of general ethical guidelines for the responsible use of such technology. These guidelines should emphasize autonomy, consent, and personal as well as interpersonal well being.
As is the case with any new area of biomedical research, practical, moral, and clinical policy considerations must be addressed in tandem with any progress made on scientific and theoretical fronts.
modulation of love-and bonding-related neural systems, under the guidance of trained professionals such as clinicians or marriage therapists, could be used to overcome, at least partially, the evolved limitations of marital well being. These neurochemical enhancers would be used in conjunction with counseling and/or other controlled activities to facilitate communication and the pursuit of joint goals and ideals between couples experiencing conflict.
Prior work on this topic has considered the possibility of neurochemical relationship enhancement using broad, conceptual strokes [1 & ,2]. This article, by contrast, attempts a finer level of scientific and practical detail. Our particular focus will be on the brain-level attachment system [30] , maintained (in large part) by the neuropeptides oxytocin and vasopressin [31, 32] . Specifically, we wish to explore the ways in which synthetic oxytocin may be used to improve the quality of romantic relationships using existing means of administration, and drawing upon recent evidence from published clinical and preclinical studies. Building upon the work of other researchers [33] , we shall postulate that oxytocin -by acting on the neural substrates of attachment -could serve as an adjunctive therapeutic agent in marriage counseling, so long as certain ethical and clinical policy considerations are taken into account.
In the following sections, we review what is known about oxytocin and the effects of oxytocin on the brain and behavior, and develop our rationale for using it to enhance relationships. We then identify a number of urgent research targets before outlining an applied program for the use of oxytocin in therapeutic settings. Finally, we address some of the most pressing ethical considerations that would necessarily arise in any attempt to 'treat' interpersonal relationships via drug-based methods.
OXYTOCIN AS A MODULATOR OF SOCIAL ATTACHMENT IN HUMANS AND OTHER ANIMALS
The neuropeptide oxytocin is present in a large number of animal species, from reptiles -in the form of vasotocin, an evolutionary precursorto mammals, encompassing the primates, and is intimately associated with social, sexual, and reproductive behaviors including mating and childbirth. Produced by the hypothalamus, oxytocin plays a dual role in modulating a wide range of essential processes: it acts as a hormone when released into the peripheral bloodstream, controlling functions such as milk letdown, uterine contraction, and cervical dilation during parturition in females;
and it acts as a neurotransmitter when released into the central nervous system, influencing social, behavioral, and motivational states in both sexes through the stimulation of its neuroreceptor targets in the hippocampus, amygdala, and nucleus accumbens as well as elsewhere throughout the brain and in the spinal cord [34] .
Animal model research points to a strong relationship between socially monogamous attachment behaviors and the expression of oxytocin within the brain -along with that of an affiliated peptide, vasopressin, and a suite of auxiliary hormones and neurotransmitters including dopamine. Notably, anatomical investigations into the mating patterns of two closely related species of vole -the monogamous prairie vole (Microtus ochrogaster) and the polygamous montane vole (Microtus montanus) -suggest that their dissimilar bonding strategies may turn upon systematic differences in the distribution of oxytocin and vasopressin receptor neurons in their brains [35] . In one study, implanting a vasopressin receptor gene into the ventral forebrain of a sample of typically promiscuous male voles caused them to behave much like their monogamous cousins [36] , while another critical experiment [37] involved manipulating hormone levels within the monogamous prairie vole species. Infusing oxytocin into the brains of the females, and vasopressin into the brains of the males, significantly enhanced pair-bonding even in the absence of actual mating.
Based upon these and similar findings, Young and Wang [38] developed a neurobiological model of rodent pair-bonding. They argued that the concurrent activation of oxytocin, vasopressin, and dopamine receptor neurons during mating activities results in the formation of a conditioned partner preference. Specifically, oxytocin and vasopressin facilitate the processing of social cues necessary for partner recognition while dopamine plays a reinforcing role by signalling reward. 'The convergence of mechanisms underlying reward, conditioning, and the neural processing of social cues,' they write, 'seems to result in the motivation to maintain selective contact with one's partner' ( [38] , p. 1053).
It has not yet been shown conclusively that human attachment relies on the same hormonal machinery as that seen in voles, but several researchers have argued that natural selection would favor conservation of so fitness-relevant a biochemical system [39, 40] . Neuroimaging studies in humans have largely substantiated this view. Mothers who observe photographs of their own infants compared against matched controls show heightened activation in brain areas rich in oxytocin, vasopressin, and dopamine neuroreceptors [41, 42] . This effect is amplified for mothers who exhibit a secure attachment style compared with those who are insecurely attached, and correlates with oxytocin levels in the blood [43] . Finally, analogous activation patterns are seen in adults who are exposed to images of their romantic partner -with whom they report being 'intensely in love' -as opposed to images of a platonic acquaintance [44] . Although none of these findings demonstrate that elevated oxytocin levels in humans directly induce greater feelings of love or interpersonal attachment -whether in the maternal-infant or adult-romantic case [45] -they do point to a clear association between oxytocin and attachment that seems to mirror what has been observed in other species.
Recent experiments have gone still further, and have attempted to investigate a potential causal relationship between the administration of oxytocin and various phenomena associated with social attachment. Using a simple nasal spray to deliver oxytocin directly into the brain -albeit in a diffuse and not entirely well-understood manner [46 && ] -key studies to date have employed a double-blind, placebo-controlled experimental design. These foundational studies have yielded a range of important discoveries. As we discuss in the following section, the latest evidence suggests that exogenously boosting oxytocin levels may result in prosocial, bond-enhancing outcomes for some individuals (or couples) under the right set of circumstances; but it may also lead to antisocial, adverse outcomes if certain dispositional and situational considerations are not taken into account.
OXYTOCIN AS A THERAPEUTIC RELATIONSHIP ENHANCER: PROMISE AND PERIL
How might oxytocin work as a therapeutic relationship enhancer? Given its central role in modulating attachment between individuals, at least in voles, and quite plausibly in humans as well, it seems reasonable to ask whether artificial oxytocin supplementation might be useful for maintaining or even improving romantic relationships. Theoretically, at least, there is good reason to think that it could. As Carter ([47] , p. 782) has summarized the effects of oxytocin on social behavior in animals: 'Oxytocin . . . may serve to inhibit defensive behaviors associated with stress, anxiety or fear, and allow positive social interactions and the development of bonds. ' In fact, oxytocin nasal spray is already being trialed as a possible treatment for specific clinical conditions that involve disrupted attachment and other problems in social processing [48] . For example, in the case of autism -a disorder known for its symptomatic social deficits -oxytocin administration increases eye-contact [49] , emotion understanding [50] , and the effectiveness of decision-making in social contexts [49] . Initial clinical studies have also shown that oxytocin administration may be useful as an adjunctive treatment for depression, anxiety, and schizophrenia, although further research is needed to confirm the reliability of these preliminary findings [51 & ]. Crucially, to the extent that individual-level symptoms associated with any of these disorders may impair relationship health or general functioning, their amelioration (via oxytocin administration or other means) would likely yield interpersonal, relational, or marital benefits as well.
Oxytocin administration has also been investigated with healthy populations. The last decade has seen a plethora of preclinical studies demonstrating prosocial effects of oxytocin in such individuals, suggesting that oxytocin-based relationship counseling may indeed be a fruitful avenue to explore. In the following sub-sections, we discuss the specific domains in which oxytocin-based therapy seems likeliest to yield relationship-level benefits, and then we turn to our analysis of potential antisocial outcomes and other complicating risk factors.
Fostering pro-relationship mindsets and behaviors
Oxytocin administration holds promise for acting in areas that are central to relationship health and functioning. Specifically, oxytocin has been shown to reduce anxiety and stress [52] [53] [54] ; boost trust [55,56,57 && ], eye-contact [58] , mind-reading [59] , and empathy [60] ; heighten the availability of positive relationship memories [61, 62] ; and improve social attention, recognition, and appraisals, as well as the encoding and retrieval of memories with social content [63 && ]. In a relationship context, these effects could increase partner approachability and cooperativeness [56, 64 & ]; increase mutual understanding and perspective-taking, thereby enhancing interpersonal learning in the therapeutic process; and increase positive relationship reflections, which are likely to be associated with successful therapy outcomes [65, 66] .
Moreover, in one study, oxytocin-primed male participants who were in a committed heterosexual relationship -but not single males -kept themselves at a significantly greater distance from an attractive female experimenter during an initial personal encounter. Such males also showed a decreased reflexive approach response when exposed to erotic images of beautiful women as measured by a computerized approach-avoidance paradigm [67 & ]. These findings suggest that intranasal oxytocin may even help to promote fidelity toward one's current partner by contributing to the ongoing maintenance of an existing monogamous pair bond.
Enhancing processing of bonding cues
A focus on pair bonding is also captured by the evolutionary-biological perspective on oxytocin, which emphasizes its role in accentuating cues related to bonding and reproductive behavior [61] . In line with this view, a study by Unkelbach, Guastella, and Forgas [68] showed that male participants were quicker to identify positively valenced stimuli associated with bonding and relationships when operating under the influence of oxytocin compared with placebo. As oxytocin can strengthen the encoding of positive social stimuli to make them more salient, it might facilitate interpersonal intimacy by making the encoding of positive social cues more rewarding and memorable [69] . 
Facilitating improved communication
A final means by which oxytocin administration may be able to enhance the effectiveness of standard therapeutic modalities is via improved communication, allowing couples to learn about each other more effectively and develop joint decisions. In a seminal study, Ditzen et al. [70] showed that oxytocin can facilitate positive communication -and reduce stress levels -in romantic couples engaged in an argument. In this double-blind, placebo-controlled study, heterosexual couples received oxytocin (versus placebo) before engaging in a conversation about a chronic source of conflict. Interactions were videotaped and coded for verbal and nonverbal communication behaviors, and salivary cortisol measures were collected. Oxytocin increased the ratio of positive to negative communication behaviors and facilitated a more rapid reduction in cortisol levels after the conflict. Importantly, couples' therapywhen it is effective -is believed to work best by enhancing partners' communication skills [71 & ]; and Gottman [72] has demonstrated that the ratio of positive to negative communication behaviors is strongly predictive of long-term relationship survival [73, 74] .
Risk factors and side-effects
These positive effects of oxytocin administration, however, constitute only part of the recent trend in research. In tension with the early wave of pro-social findings associated with oxytocin (see Table 1 for a selective summary), more recent studies have pointed to a potential 'dark side' as well [75 & ,76] . Indeed, more troubling consequences of oxytocin administration are increasingly being uncovered, showing that oxytocin can have a range of different effects, on different people, under different circumstances. For example, Shamay-Tsoory et al. [77] have shown that, in addition to promoting empathy and generosity, oxytocin can increase feelings of envy and schadenfreude. DeClerck et al. [78] found that people behave more cooperatively under the influence of oxytocin when interacting with familiar targets, but less cooperatively if the target is a stranger. And De Dreu et al. [79] demonstrated that oxytocin can increase in-group favoritism (ethnocentrism) while at the same time potentially magnifying out-group prejudice. These results suggest that oxytocin may ultimately turn out to be a 'double-edged sword' -capable of 'promoting bonds with familiar individuals, but promoting unfriendly behavior toward strangers' ( [75 & ], p. 269). By the same token, distinct personality traits have recently been associated with negative effects of oxytocin on behavior. Bartz et al. [80] , for example, showed that patients with borderline personality disorder may exhibit decreased trust and cooperativeness under the influence of oxytocin. In addition, individuals who are anxiously attached have been shown to be likelier to remember their own mothers as being less close and caring [81] . And oxytocin seems to improve empathic accuracy only in less socially proficient individuals, whereas it has no effect for those who are already well attuned to social information [69] . These and other newer findings complicate the notion that oxytocin can serve as a universal 'enhancer' of social-cognitive behaviors. Indeed, as Bartz ' The investigation of individual differences in reactivity to oxytocin is likely to be of profound importance . . . key markers [are needed] that can index variation in the degree to which people are affected by the spray, and how this variation is associated with changes in underlying circuitry. ' Significant work is needed, therefore, to create an anthology of both benefit and risk factors ( Table 2 ) that would mitigate either in favor of or against the prescribed use of oxytocin. These might include certain personality traits (i.e., bipolar disorder, borderline personality disorder, and insecure attachment styles), genetic profiles (including genes that control for the distribution of oxytocin and vasopressin receptors within the brain), and relevant situational factors. Couples would need to be screened for any complicating variables prior to oxytocin administration, and any individuals who were at a high risk for outcomes that were either predominantly or severely unfavorable might need to be excluded from oxytocin-based treatment plans.
At the same time, however, it would be premature to conclude that oxytocin should never be administered in such 'problematic' cases. Rather, the existence of possible risk factors for certain individuals suggests that greater initial effort may be required to determine what sort of psychotherapeutic contexts and treatment paradigms would be needed to ensure that such administration resulted in net benefits rather than net harms. In other words, the possibility that oxytocin could prove advantageous (on balance) even for individuals with 'risky' profiles -by, for example, facilitating the development of healthier relationship schemas with the guidance of a counselor or therapist -must not be ruled out in advance of attempting the necessary research.
Indeed, the potential for negative effects of oxytocin administration in general should be considered in a proper context. With regard to findings that oxytocin may increase feelings of envy (or decrease cooperation) during interactions with unfamiliar targets, for instance, it must be remembered that romantic partners are not strangers to each other. Hence it seems reasonable to hypothesize that at least these types of problematic outgroup or stranger-driven effects would be unlikely to occur in a counseling setting. Furthermore, even if oxytocin administration does turn out to promote such troubling phenomena as in-group favoritism (at the expense of more altruistic out-group judgments), two further conditions would have to be met before these sorts of effects would count against the desirability of attempting oxytocin-based therapy.
First, it would have to be shown that any outgroup negativity extended beyond the time-frame of the counseling session in which the 'in-group' therapeutic effects were being harnessed or explored. Second, it would need to be shown that such 'bad' effects were stronger when oxytocin is administered exogenously (i.e., through a nasal Unkelbach et al. [68] Emotion detection and recognition Bartz et al. [69] Hurlemann et al. [60] Guastella et al. [50] Positive communication behavior Ditzen et al. [70] spray) than when it is released endogenously by the hypothalamus. This is because couples who were trying to improve their relationship through an increased pursuit of intimate activities, such as mutual touching or engaging in sexual intercourseboth of which trigger the endogenous release of oxytocin -should not be expected to refrain from these activities simply because they might inspire a transitory in-group bias. These considerations show how important it will be, going forward, to study the effects of oxytocin on human judgment and behavior 'outside of the lab.' In other words, the effects of a single dose of oxytocin on highly sensitive, quick-tofollow dependent measures -such as is typical for current research -need to be systematically compared against the effects of more ecologically valid drug administrations. Such a comparison would require the investigation of chronic (therapeutic) applications on longer-term attitudinal and behavioral tendencies, as well as the careful examination of any 'natural' effects of fluctuating oxytocin levels stemming from ordinary activities and behaviors.
Additional gaps
There are number of additional gaps in our current understanding as well. If any large-scale therapeutic programs are to be attempted, we suggest, these gaps will need urgently to be filled (see Table 3 ). First, future studies should carefully evaluate the effects of oxytocin administration on both males and females. A majority of studies to date have been restricted to men [33] and it will be important to investigate how and to what extent any positive outcomes might generalize to both sexes, particularly in a relationship context. Second, much more work is needed to uncover the means by which oxytocin exerts its various effects [83] . As Young [quoted in Miller ([75 & ], p. 296)] has stated: 'If we want to move beyond this initial investigatory era and get more sophisticated and potent effects, we need to understand the mechanisms. ' Third, dosing and safety guidelines need to be established. For example, it will be important to determine whether oxytocin might have addictive properties, particularly at high doses. While there is no evidence to date that oxytocin does have such properties, there could be a potential problem with 'demand characteristics' -that is, the expectation that a drug is having some effect, leading one to do things that one would otherwise not do. At the same time, however, several studies have reported that individuals who are given intranasal oxytocin do not report feelings of euphoria or any sort of conscious knowledge of being administered the drug as compared with a placebo [84] . Regarding dosages, these range (in current research) from 18 to 40 IU, and from single instances of administration to up to 182. Yet 'the dose that has been most widely used (24 IU) ]. This will be especially important for determining whether oxytocin might be useful for 'problematic' cases such as those described above. And seventh, ecological validity needs to be investigated. As we noted earlier, many of the current findings -both 'promising' and 'perilous' -stem from single administrations of oxytocin in a laboratory setting. Very little is known about long-term effects of such administration in the 'real world' of either individuals' or couples' lives.
Practical considerations
What about more practical concerns about the use of oxytocin in applied settings? Even as the numerous extant research-gaps begin to be addressed, it will be essential for couples seeking to improve their relationships with adjunct oxytocin-based treatments to do so under the guidance of a trained professional. This professional should be responsible for undertaking any prescreening requirements as noted above, and should ensure that careful monitoring of the relationship takes place at regular intervals [66] . Finally, it would be imperative to confirm that both partners had given their informed consent to undertaking drug-based relationship treatment and that treatment could be stopped at the request of either partner.
ETHICAL IMPLICATIONS OF OXYTOCIN-BASED RELATIONSHIP THERAPY
In addition to policy considerations concerning research aims and clinical practice, the prospect of using an exogenously administered chemical substance to 'treat' or even 'enhance' an interpersonal relationship raises a number of pressing ethical questions as well. First, a caution must be raised regarding the specific role of oxytocin in modulating both trust and aversion to betrayal in the context of romantic relationships. In a seminal study, Kosfeld et al. [55] demonstrated that intranasally administered oxytocin can increase an individual's willingness to 'accept social risks arising through interpersonal interactions.' In addition, De Dreu [85] recently showed that oxytocin can promote cooperation in some individuals by reducing their aversion to being betrayed. Yet, within certain partnerships, an instinctive unwillingness to suffer repeated betrayals of trust could be vital for protecting the health and well being of the individual so betrayed. In this situation, oxytocin administration might diminish one's ability to recognize the risks associated with trusting one's partner, who might then go on to break one's trust again.
This consideration highlights the importance of being able to determine what sorts of factors should be considered constitutive of healthy vs. unhealthy relationships in the first instance -that is, those worth sustaining or even enhancing (through therapeutic interventions or by other means), and those in need of re-evaluation or even termination. Although couples have typically been encouraged to find their own answers to these difficult questions, we suggest that the imminent prospect of neurochemical modulation of human relationships calls for the development of more general ethical guidelines concerning when and how to deploy these potentially potent new technologies. We have argued elsewhere that such guidelines should be tied to a robust account of personal and interpersonal well being [86] , and should be sensitive to potential harms that may impact upon the lives of children and other vulnerable parties [1 & ]. Within the context of these more general principles, however, any oxytocin-based treatment plan will have to take into consideration the specific contextual factors that apply to the unique situation of each individual couple. While some couples may benefit from trust-enhancing interventions, for example, other couples may be put at risk, as we noted above. In addition, although problematic 'stranger' or 'out-group' effects would seem to be less of a general concern for romantic couples, it is conceivable that some relationships will have deteriorated to such a degree that the individuals involved do indeed 'feel like strangers' to each other. Future research should attempt to determine whether oxytocin may have positive or negative effects in situations such as these.
Yet, while the existence of negative effects in early trials may simply point to the need to develop complementary administration paradigms -that is, paradigms that could moderate or even reverse these 'bad' effects in applied settings -the importance of prescreening and the close involvement of a trained professional in any therapeutic program cannot be overstated.
Serious care must also be taken to avoid any form of coercion. A particularly problematic situation might arise if one of the partners in a relationship sought to cajole the other partner into remaining in the relationship against his or her wishes, whether by pursuing oxytocin-based therapy or otherwise. Additionally, partners might disagree on the extent to which they believe that the relationship is worth strengthening. These kinds of worries can be allayed by the conditions indicated earlier: oxytocin administration should only be pursued if both partners autonomously agree to the treatment; and oxytocin should only be administered when it is based on sound ethical reflection, in the context of a structured treatment plan, with the careful guidance of a professional trained in counseling.
CONCLUSION
Positive interpersonal relationships are healthy. They may even be as important for the promotion of health and well being as any number of more widely discussed public health priorities. Indeed, a recent meta-analysis showed that well-functioning social relationships are as essential to good health as exercising and refraining from smoking [87] . By contrast, relationship dysfunction as well as social isolation and outright loneliness are threatening to health, and can lead to such outcomes as depression, illness, elevated levels of latent herpes virus reactivation, and even inflamed immune responses. Research has shown that this type of inflammation may contribute to such ills as coronary heart disease, Type 2 diabetes, arthritis, and Alzheimer's disease [88, 89] . If relationship dysfunction, therefore, turns out to be at the 'root' of such serious problems as heart disease or arthritis, then treatment modalities aimed at addressing relationship functionality in the first instance would seem to be well worth investigating.
Toward this end, however, neurochemical interventions designed to promote interpersonal health and well being as a complement to existing therapeutic strategies have gone largely unexplored. Accordingly, we have reviewed a range of preliminary studies that show that the exogenous administration of oxytocin may confer a number of pro-social outcomes, and we have argued that these effects could serve to enhance at least some romantic relationships. Large-scale, carefully controlled clinical trials are needed to determine which people (including which couples), under which specific conditions, would be most likely to benefit from oxytocin-based treatments; and a detailed profile of risk factors and contra-indications needs to be compiled as well. Such efforts will inevitably raise a number of clinical, policy, and ethical considerations that must be addressed in tandem with any progress made on scientific and theoretical fronts. By anticipating some of these considerations, we hope to have contributed our part to this exciting new area of research.
